A PHASE II STUDY OF S-1 COMBINED WITH IRINOTECAN AND OXALIPLATIN IN PATIENTS WITH METASTATIC GASTRIC CARCINOMA

被引：0
|
作者：
Park, S. R. [1 ]
Park, Y. [1 ]
Park, Y. L. [1 ]
Kim, N. K. [1 ]
机构：
[1] Natl Canc Ctr, Res Inst Hosp, Branch Gastr Canc, Goyang 411769, Gyeonggi, South Korea
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [21] A phase II study of S-1 and oxaliplatin as first-line therapy for patients with recurrent or metastatic gastric cancer
    Kim, H.
    Lee, G.
    Kim, H.
    Lee, O.
    Hwang, I.
    Kang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] A PHASE II STUDY OF S-1 AND OXALIPLATIN AS FIRST-LINE THERAPY FOR PATIENTS WITH RECURRENT OR METASTATIC GASTRIC CANCER
    Kim, H. G.
    Kang, M.
    Kim, S.
    Lee, S. I.
    Lee, G.
    Kang, J. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 182 - 182
  • [23] PHASE II TRIAL OF COMBINED CHEMOTHERAPY WITH IRINOTECAN, S-1, AND BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Komatsu, Y.
    Yuki, S.
    Sogabe, S.
    Nakamura, M.
    Hatanaka, K.
    Miyagishima, T.
    Kudo, M.
    Munakata, M.
    Sakata, Y.
    Asaka, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 197 - 197
  • [24] Phase II trial of combined chemotherapy with irinotecan, S-1, and bevacizumab in patients with metastatic colorectal cancer
    Hatanaka, K.
    Komatsu, Y.
    Yuki, S.
    Nakamura, M.
    Miyagishima, T.
    Kudo, M.
    Munakata, M.
    Sakata, Y.
    Asaka, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 336 - 336
  • [25] Irinotecan combined with S-1 for advanced gastric cancer - Results of phase II study and gene expressions
    Inokuchi, Mikito
    Kojima, Kazuyuki
    Yamada, Hiroyuki
    Hayashi, Mikiko
    Sugihara, Kenichi
    GASTROENTEROLOGY, 2006, 130 (04) : A894 - A894
  • [26] Phase II study of docetaxel, oxaliplatin and S-1 (DOS) for patients with advanced gastric cancer
    Zang, D.
    Kang, Y.
    Ryu, B.
    Ryu, M.
    Lee, S.
    Kim, H.
    Kim, J.
    Jung, J.
    Kwon, J.
    Kim, H.
    EJC SUPPLEMENTS, 2009, 7 (02): : 375 - 375
  • [27] Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer
    Sung Yong Oh
    Young-Tae Ju
    Sang-Kyung Choi
    Chang Yoon Ha
    Won Sup Lee
    Hoon Gu Kim
    Gyeong-Won Lee
    Hyuk-Chan Kwon
    Jung Hun Kang
    Investigational New Drugs, 2011, 29 : 1050 - 1056
  • [28] Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer
    Oh, Sung Yong
    Ju, Young-Tae
    Choi, Sang-Kyung
    Ha, Chang Yoon
    Lee, Won Sup
    Kim, Hoon Gu
    Lee, Gyeong-Won
    Kwon, Hyuk-Chan
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 1050 - 1056
  • [29] Phase II study of SOXIRI (S-1/oxaliplatin/irinotecan) chemotherapy in patients with unresectable pancreatic ductal adenocarcinoma
    Wang, Fenghua
    Wang, Yixing
    Ren, Chao
    Li, Xujia
    Qiu, Miaozhen
    Li, Yuhong
    Luo, Huiyan
    Peng, Ruojun
    Quan, Qi
    Jiang, Qi
    Li, Shengping
    Guo, Guifang
    PANCREATOLOGY, 2024, 24 (02) : 241 - 248
  • [30] Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
    Yoo, Changhoon
    Han, Boram
    Kim, Hyeong Su
    Kim, Kyu-pyo
    Kim, Deokhoon
    Jeong, Jae Ho
    Lee, Jae-Lyun
    Kim, Tae Won
    Kim, Jung Han
    Choi, Dae Ro
    Ha, Hong Il
    Seo, Jinwon
    Chang, Heung-Moon
    Ryoo, Baek-Yeol
    Zang, Dae Young
    CANCER RESEARCH AND TREATMENT, 2018, 50 (04): : 1324 - 1330
12345